infection epidemiology during the COVID-19 pandemic in Greece.

The aim was to highlight the incidence and epidemiology of infections (CDI) in a tertiary Greek hospital during the COVID-19 pandemic. A single-center prospective observational cohort study was conducted (October 2021 until April 2022). 125 isolates were cultured from hospitalized patients stool samples and screened by PCR for toxin A (), toxin B (), binary toxin ( and ) genes and the regulating gene of .

Implication of COVID-19 pandemic on the incidence of infection in a Greek tertiary hospital.

infection (CDI) represents an important global threat. In the COVID-19 era, the multifactorial nature of CDI has emerged. The aim was to assess the impact of COVID-19 pandemic on the incidence of CDI in a Greek hospital.

COVID-19 and Antimicrobial Resistance: Data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance-WHONET-Greece (January 2018-March 2021).

Changes in hospitals' daily practice due to COVID-19 pandemic may have an impact on antimicrobial resistance (AMR). We aimed to assess this possible impact as captured by the Greek Electronic System for the Surveillance of Antimicrobial Resistance (WHONET-Greece). Routine susceptibility data of 17,837 Gram-negative and Gram-positive bacterial isolates from blood and respiratory specimens of hospitalized patients in nine COVID-19 tertiary hospitals were used in order to identify potential differences in AMR trends in the last three years, divided into two periods, January 2018-March 2020 and April 2020-March 2021.

A rare case of polymicrobial chronic maxillary sinusitis due to concurrent isolation of Parvimonas micra and Fusobacterium nucleatum.

Parvimonas micra and Fusobacterium nucleatum are commensal pathogens very rarely isolated simultaneously in clinical specimens. We report a case of chronic maxillary sinusitis caused by these two pathogens, presumably resulting from a co-existing dental infection.

Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013.

Purpose To evaluate the in vitro efficacy of several anti-staphylococcal agents against a nationwide collection of contemporary Staphylococcus aureus clinical isolates from several healthcare centres in Greece. Methods Thirty hospitals throughout Greece (18 in Attica) provided all clinical isolates of S.aureus from April 2012 to May 2013 to a central lab to be re-submitted to susceptibility testing.